Want to see HCTI full AI Analyst Report?
Top Page
Healthcare Triangle
(NASDAQ:HCTI)
Select Model
Select Model
Rating:44Neutral
Price Target:
$0.81
▼(-3.33% Downside)
Action:Reiterated
Date:08/17/26
The score is weighed down primarily by weak financial performance—deep operating/net losses and heavy negative free cash flow despite the revenue rebound. Technicals also remain bearish with price below key moving averages and negative MACD. Corporate actions provide some support via improved listing cushion and financing access, but the financing structure adds dilution risk, and valuation inputs are not informative due to missing/invalid P/E and no dividend.
Positive Factors
Revenue rebound
The revenue rebound indicates renewed demand for Healthcare Triangle’s healthcare IT and digital transformation services. Sustained customer adoption could support future scale if the company converts project work into larger, multi-phase and recurring managed-services engagements.
Negative Factors
Severe unprofitability
Revenue growth is not currently translating into economic returns. Low gross margin and very large operating and net losses indicate that the cost structure is not scaling, limiting the company’s ability to reinvest, withstand setbacks or become self-funding.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue rebound
The revenue rebound indicates renewed demand for Healthcare Triangle’s healthcare IT and digital transformation services. Sustained customer adoption could support future scale if the company converts project work into larger, multi-phase and recurring managed-services engagements.
Read all positive factors
Healthcare Triangle (HCTI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$12.55M
Dividend YieldN/A
Average Volume (3M)1.85M
Price to Earnings (P/E)―
Beta (1Y)0.24
Revenue Growth116.40%
EPS Growth99.31%
CountryUS
Employees41
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-65.57
Shares Outstanding14,974,322
10 Day Avg. Volume1,253,213
30 Day Avg. Volume1,845,381
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.24
Price to Sales (P/S)0.17
P/FCF Ratio-0.14
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-10.96
Revenue Forecast (FY)$42.48M
Healthcare Triangle Business Overview & Revenue Model
Company Description
Healthcare Triangle, Inc. (HCTI) is a technology firm dedicated to the healthcare sector, specializing in crafting innovative solutions across cloud services, data science, and professional and managed IT support. The company provides a comprehens...
How the Company Makes Money
HCTI primarily makes money by delivering services and solutions to healthcare and life-sciences customers under commercial agreements. Key revenue streams include: (1) Professional services/implementation revenue from project-based work such as cl...
Healthcare Triangle Financial Statement Overview
Summary
Income Statement
18
Very Negative
Balance Sheet
43
Neutral
Cash Flow
12
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 25.68M | 13.89M | 11.70M | 33.20M | 45.89M | 35.27M |
| Gross Profit | 4.72M | 1.89M | 2.89M | 6.78M | 11.29M | 10.52M |
| EBITDA | -14.66M | -8.20M | -3.85M | -6.12M | -10.70M | -3.94M |
| Net Income | -17.02M | -9.48M | -5.97M | -8.69M | -14.36M | -5.95M |
Balance Sheet | ||||||
| Total Assets | 73.64M | 22.74M | 1.96M | 6.86M | 13.26M | 24.61M |
| Cash, Cash Equivalents and Short-Term Investments | 1.91M | 7.63M | 20.00K | 1.23M | 1.34M | 1.77M |
| Total Debt | 13.00M | 10.74M | 2.65M | 3.88M | 2.69M | 3.45M |
| Total Liabilities | 24.63M | 12.79M | 7.08M | 8.25M | 7.22M | 8.48M |
| Stockholders Equity | 49.10M | 9.98M | -5.11M | -1.39M | 6.04M | 16.14M |
Cash Flow | ||||||
| Free Cash Flow | -23.66M | -16.52M | -1.08M | -2.16M | -6.49M | -10.24M |
| Operating Cash Flow | -16.11M | -16.52M | -1.08M | -2.15M | -5.35M | -7.11M |
| Investing Cash Flow | -10.39M | -1.75M | 0.00 | -12.00K | -1.13M | -7.63M |
| Financing Cash Flow | 25.15M | 25.88M | -133.00K | 2.06M | 6.06M | 15.11M |
Healthcare Triangle Technical Analysis
Negative
0.84
Price Trends
1.54
Negative
1.94
Negative
25.97
Negative
Market Momentum
-0.20
Positive
34.14
Neutral
3.75
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HCTI, the sentiment is Negative. The current price of 0.84 is below the 20-day moving average (MA) of 1.09, below the 50-day MA of 1.54, and below the 200-day MA of 25.97, indicating a bearish trend. The MACD of -0.20 indicates Positive momentum. The RSI at 34.14 is Neutral, neither overbought nor oversold. The STOCH value of 3.75 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HCTI.
Healthcare Triangle Risk Analysis
Healthcare Triangle disclosed 43 risk factors in its most recent earnings report. Healthcare Triangle reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Healthcare Triangle Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | $733.09M | 79.83 | 2.79% | ― | 14.05% | ― | |
70 Outperform | $4.84B | 36.44 | 3.59% | ― | 19.23% | 44.44% | |
68 Neutral | $113.03M | 35.67 | 16.56% | ― | 15.07% | ― | |
60 Neutral | $119.66M | -0.43 | -129.70% | ― | -7.54% | -143.41% | |
52 Neutral | $518.94M | -1.02 | -99.16% | ― | -4.50% | -184.71% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
44 Neutral | $12.55M | -0.01 | -68.42% | ― | 116.40% | 99.31% |
* Healthcare Sector Average
HCTI
Healthcare Triangle
0.84
-135.36
-99.38%
CCLD
CareCloud
2.49
-1.35
-35.16%
EVH
Evolent Health
4.60
-5.05
-52.33%
PHR
Phreesia
12.15
-19.51
-61.62%
HCAT
Health Catalyst
1.59
-1.80
-53.10%
WAY
Waystar Holding Corp.
26.24
-11.64
-30.73%
Healthcare Triangle Corporate Events
Business Operations and StrategyDelistings and Listing ChangesM&A TransactionsRegulatory Filings and ComplianceShareholder Meetings
Healthcare Triangle Expands Share Base, Strengthens Nasdaq Standing
Positive
Jul 29, 2026
On July 24, 2026, Healthcare Triangle completed the issuance of 12,546,540 common shares tied to two previously approved legacy MA transactions: the acquisition involving Teyame AI LLC and a share exchange agreement with SecureKloud Technologies L...
Business Operations and StrategyPrivate Placements and FinancingShareholder Meetings
Healthcare Triangle Shareholders Approve Key Governance Measures
Positive
Jul 20, 2026
At its virtual annual meeting on July 17, 2026, Healthcare Triangle shareholders backed all board nominees for one-year terms and ratified SRCO Professional Corporation as the independent auditor for the 2026 fiscal year. Investors representing ab...
Business Operations and StrategyM&A TransactionsPrivate Placements and FinancingRegulatory Filings and Compliance
Healthcare Triangle Creates New Series C Preferred Stock
Positive
Jun 26, 2026
On June 24, 2026, Healthcare Triangle agreed a securities exchange with SecureKloud Technologies Ltd., issuing 2,828,167 common shares as a make-whole in return for SecureKloud’s Series B preferred stock, which had lost much of its conversio...
Business Operations and StrategyPrivate Placements and Financing
Healthcare Triangle Secures New Convertible Financing and Liquidity
Positive
Jun 15, 2026
On June 12, 2026, Healthcare Triangle completed a private placement of 15% original issue discount senior convertible promissory notes with an aggregate principal amount of $4.235 million, raising roughly $3.6 million in gross proceeds before fees...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.